About this trial

This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.

Eligibility criteria

Qualifiers

diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;

all patients were diagnosed as PVT by CTA at admission.

Disqualifiers

patients with hepatocellular carcinoma;

patients with extrahepatic malignancies;

history of liver transplantation or TIPS;

lack of information regarding anticoagulation therapy;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
200032, ShanghaiShanghai Municipality, China

Sponsors and collaborators

Shanghai Zhongshan Hospital

Lead sponsor